Company Profile

NeuroBioTex Inc
Profile last edited on: 12/14/2023      CAGE: 4CVU6      UEI: J5SGWMMHPAH8

Business Identifier: Zinc-Based Diagnostics and Research Tools
Year Founded
1999
First Award
1988
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 Christopher Columbus Boulevard
Galveston, TX 77550
   (409) 762-0678
   c.j.frederickson@neurobiotex.com
   www.neurobiotex.com
Location: Single
Congr. District: 14
County: Galveston

Public Profile

NeuroBioTex, Inc. is a medical research and technology development firm specializing in matters pertaining to zinc and health, with particular emphasis on the roles of zinc in normal and abnormal brain function. The firm develops research tools, diagnostics, and therapeutics for diseases involving zinc. The company focuses on ionic zinc signals, including the cells that secrete them, the channels through which they travel, and the receptors that are tuned to the zinc signals. It also develops diagnostic and therapeutic tools for the clinician to diagnose and treat disorders stemming from disturbances of the concentrations of free zinc in organisms or tissues. The company’s products include low zinc reagents, precise free zinc measurement instruments, zinc traps, zinc stains and probes, and zinc-buffers and media.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 2 NIH $1,529,197
Project Title: Portable Instrument for Assessing Zinc Deficiency in Children and the Elderly
2010 2 NIH $1,263,887
Project Title: Zinc-Based Diagnostic for Prostate Cancer
2006 2 NIH $1,062,233
Project Title: Zinc Sensors for Neurology and Neuroscience
2006 1 NIH $338,500
Project Title: Flourescent Tools for the Study of Metallothionein
2004 2 NIH $606,335
Project Title: High-Speed Microfluidic Sorting of Biohazardous Cells

Key People / Management

  Christopher J Frederickson -- CEO & CTO

  Cathleen Frederickson -- Owner

  Leo Giblin